615 related articles for article (PubMed ID: 22245962)
1. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
Stepanova M; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
[TBL] [Abstract][Full Text] [Related]
2. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
[TBL] [Abstract][Full Text] [Related]
4. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
Ong JP; Pitts A; Younossi ZM
J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up.
Zelber-Sagi S; Lotan R; Shibolet O; Webb M; Buch A; Nitzan-Kaluski D; Halpern Z; Santo E; Oren R
Liver Int; 2013 Oct; 33(9):1406-12. PubMed ID: 23656177
[TBL] [Abstract][Full Text] [Related]
8. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
9. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
Pacana T; Fuchs M
Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups.
Smits MM; Ioannou GN; Boyko EJ; Utzschneider KM
J Gastroenterol Hepatol; 2013 Apr; 28(4):664-70. PubMed ID: 23286209
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
[TBL] [Abstract][Full Text] [Related]
13. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Sung KC; Ryan MC; Wilson AM
Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
Lazo M; Hernaez R; Eberhardt MS; Bonekamp S; Kamel I; Guallar E; Koteish A; Brancati FL; Clark JM
Am J Epidemiol; 2013 Jul; 178(1):38-45. PubMed ID: 23703888
[TBL] [Abstract][Full Text] [Related]
15. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
16. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
[TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α.
Ajmal MR; Yaccha M; Malik MA; Rabbani MU; Ahmad I; Isalm N; Abdali N
Indian Heart J; 2014; 66(6):574-9. PubMed ID: 25634387
[TBL] [Abstract][Full Text] [Related]
19. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]